Human C-peptide Dose Dependently Prevents Early Neuropathy in the BB/Wor-rat

In order to explore the neuroprotective and crossspecies activities of.C-peptide on type 1 diabetic neuropathy, spontaneously diabetic BB/W-rats were given increasing doses of human recombinant Cpeptide (hrC-peptide). Diabetic rats received 10, 100, 500, or 1000 μg of hrC-peptide/kg body weight/ day...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, W., Yorek, M., Pierson, C. R., Murakawa, Y., Breidenbach, A., Sima, A. A. F.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2001
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2478548/
https://www.ncbi.nlm.nih.gov/pubmed/12369706
http://dx.doi.org/10.1155/EDR.2001.187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2478548/
https://www.ncbi.nlm.nih.gov/pubmed/12369706
http://dx.doi.org/10.1155/EDR.2001.187

Ejemplares similares